Information

This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

Confirm

Key Opinions in Medicine

  • Register
  • Login
Skip to content
  • Issues
    • Allergy & Immunology
    • Cardiology
    • Conference
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes & Endocrinology
    • Gastroenterology
    • General Medicine
    • Haematology
    • Hepatology
    • Infectious Diseases
    • Metabolic Disorders
    • Neurology
    • Nursing
    • Obstetrics & Gynaecology
    • Oncology
    • Paediatrics
    • Psychiatry
    • Rheumatology
    • Surgery Insights
    • Urology
  • Register
  • Login

download

Treatment of Onychomycosis with Ciclopirox Medicated Nail Lacquer

Treatment of Onychomycosis with Ciclopirox Medicated Nail Lacquer

Onychomycosis is a fungal infection of the nail plate/bed.1 It is one of the most frequent nail disorders in adults and accounts for 15%-40% of all nail diseases.2 The risk factors for onychomycosis...

Langfristige Therapiekonzepte der Atopischen Dermatitis:

Langfristige Therapiekonzepte der Atopischen Dermatitis:

Patienten mit Atopischer Dermatitis (AD) benötigen langfristige Therapiekonzepte. Voraussetzung dafür ist, neben hoher Wirksamkeit, auch ein gutes Sicherheitsprofil. Seit Juni 2021 bereichert der...

Chronic complement-mediated hemolysis in cold agglutinin disease drives year-round anemia regardless of the season

Chronic complement-mediated hemolysis in cold agglutinin disease drives year-round anemia regardless of the season

Cold agglutinin disease (CAD) is a rare type of autoimmune hemolytic anemia characterized by chronic hemolysis.1 CAD usually affects people between the ages of 40 and 80 years. The median age at ...

Drei-Jahres-Daten für IL-17A- und IL-17F-Inhibitor bei mittelschwerer bis schwerer Plaque-Psoriasis

Drei-Jahres-Daten für IL-17A- und IL-17F-Inhibitor bei mittelschwerer bis schwerer Plaque-Psoriasis

Langzeitdaten aus der BE BRIGHT-Verlängerungsstudie basierend auf der BE SURE-Studie belegen, dass ein Großteil der Patient:innen, die in Woche 16 eine vollständige Erscheinungsfreiheit der Haut...

Alpelisib in the treatment of hormone receptor-positive and human epidermal growth factor receptor 2-negative PIK3CA-mutated advanced breast cancer

Alpelisib in the treatment of hormone receptor-positive and human epidermal growth factor receptor 2-negative PIK3CA-mutated advanced breast cancer

Cancers associated with hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) status account for >70% of all breast cancers.1 About 40% of HR+/HER2- cancers...

Exploring Factor XI: A Paradigm Shift Towards Hemostasis-Sparing Anticoagulation

Exploring Factor XI: A Paradigm Shift Towards Hemostasis-Sparing Anticoagulation

The 2022 Biotechnology Innovation Organization (BIO) International Convention The BIO International Convention took place in San Diego, CA, on 13–16 June 2022. BIO is the world’s largest advocacy...

Overview of the diagnosis and treatment of thrombotic thrombocytopenic purpura

Overview of the diagnosis and treatment of thrombotic thrombocytopenic purpura

Thrombotic thrombocytopenic purpura (TTP) is a life-threatening blood disorder that occurs in 2 to 11 cases per million people.1–4 TTP is characterized by a severe deficiency in the enzyme von...

Overview of the diagnosis and treatment of human cytomegalovirus

Overview of the diagnosis and treatment of human cytomegalovirus

The human cytomegalovirus (CMV) is a common virus belonging to the herpes virus family with a global seroprevalence of 40–100%.1–3 Although usually latent and asymptomatic, CMV is a lifelong...

Prurigo nodularis

Prurigo nodularis

Prurigo nodularis (PN) ist eine chronische, progressive, entzündliche Hauterkrankung, welche die Lebensqualität der Betroffenen enorm beeinträchtigt.1,2 Im Rahmen eines Pressefrühstücks...

FOCUS Cataract Refractive Symposium

FOCUS Cataract Refractive Symposium

 

Sydney 4 June 2022 and Brisbane 18 June 2022

  The Alcon FOCUS Cataract Refractive Symposium was held on Saturday 4 June 2022 at the Hyatt Regency Sydney and Saturday 18 June 2022 at the Westin Hotel, Brisbane to a combined audience of...

1 … 4 5 6 7 8 … 38

Search Issues

RSS Feeds

  • All issues

Popular Issues

Konkurrenz für den Therapiestandard

MOVICOL® (PEG3350 plus electrolytes): 20 years of evidence-based use

Copyright © 2000-2025 by John Wiley & Sons, Inc., or related companies. All rights reserved.
Review our privacy policy. Cookie Preferences.
Web design and marketing agency Leamington Spa